Clinical Trials Logo

Bladder Cancer Stage II clinical trials

View clinical trials related to Bladder Cancer Stage II.

Filter by:
  • None
  • Page 1

NCT ID: NCT06358599 Completed - Bladder Cancer Clinical Trials

The Impact of Neoadjuvant Chemotherapy on Survival Outcomes in Patients With Variant Histologies Bladder Cancer Who Underwent Radical Cystectomy

Start date: January 7, 2021
Phase:
Study type: Observational

The World Health Organization 2016 bladder tumor classification reported that the diagnosis of variant histology has increased from 6% to 33% in the last 2 decades, and there is an increasing interest in investigating the effects on disease management, treatment options, and survival outcomes in bladder tumors with variant histology. In bladder tumors, variant histology is known to be more aggressive and has a worse prognosis than pure urothelial cancer, and most cases are muscle invasive at diagnosis. Neoadjuvant cisplatin-containing combination chemotherapy is known to improves overall survival in patients with urothelial cancers. However, it is unclear whether patients with non-pure urothelial cancer (variant) histology will also benefit from neoadjuvant chemotherapy. The investigators aimed to evaluate the role of Neoadjuvant cisplatin-containing combination chemotherapy in the final treatment plan and its impact on survival in patients with bladder cancer who were diagnosed with variant histology in the radical cystectomy specimen.

NCT ID: NCT06170177 Recruiting - Bladder Cancer Clinical Trials

Study on the Quality of Life and Pathological State in Patients Who Underwent Radical Cystectomy

Start date: February 4, 2013
Phase:
Study type: Observational

Observational study on the quality of life and pathological state of patients underwent radical cystectomy.

NCT ID: NCT04806334 Terminated - Clinical trials for Bladder Cancer Stage II

Radiogenomics of Muscle Invasive Bladder Cancer

Start date: March 2, 2021
Phase: N/A
Study type: Interventional

Patients with suspected bladder tumor will undergo novel 4D MRI imaging along with single cell RNA sequencing in hopes of identifying a radiogenomic signature that can improve our staging of patients with muscle invasive bladder cancer.

NCT ID: NCT04598724 Completed - Clinical trials for Muscle-Invasive Bladder Carcinoma

Addressing Barriers to Palliative Care Use in Bladder Cancer

Start date: December 22, 2020
Phase:
Study type: Observational

Investigators plan to establish an in-depth understanding of knowledge and beliefs about palliative care in advanced Bladder Cancer patients and their caregivers, and to identify factors associated with positive and negative experiences with palliative care services among those who have received them.

NCT ID: NCT03522155 Recruiting - Clinical trials for Bladder Cancer Stage II

Patient-Centered Communication of Life Expectancy Estimates in Genitourinary Malignancies

Start date: September 1, 2021
Phase: N/A
Study type: Interventional

Investigators will conduct a randomized trial to determine if providing patient-specific life expectancy estimates during treatment counseling via a targeted, patient-centered communication approach improves shared decision making and reduces rates of overtreatment of genitourinary malignancies.